Skip to main content

CBD In Food & Beverage: Three Developments To Watch In 2020

Hand holding pipette with CBD oil on wooden table

While products containing CBD are widespread, new legal developments are expected in 2020 that may … [+] affect how the products are marketed and sold in certain jurisdictions.

Getty

The cannabidiol (CBD) industry saw considerable growth in 2019, and the industry is expected to see further expansion over the new year. In the absence of clear federal guidance, sellers of products containing CBD, particularly those in the food and beverage space, should watch how three developments might affect their products and the industry as a whole.

  • Further FDA Clarification: The U.S. Food and Drug Administration (FDA) announced in November 2019 that the agency had numerous “unanswered questions and data gaps about CBD toxicity” and issued over a dozen warning letters to sellers of CBD-containing products. The FDA’s updated Consumer Update declared that marketing CBD “by adding it to a food or labeling it as a dietary supplement” is illegal. In its announcement, the FDA noted that it is continuing to explore “potential pathways for various types of CBD products to be lawfully marketed” and expects to provide an update on its “progress regarding the agency’s approach to these products in the coming weeks.” After the agency’s November announcement and warning letters, manufacturers of CBD products, particularly those in food and beverage categories, should watch how the FDA clarifies and enforces its position on CBD-containing products over the new year.
  • State and Local Action: Without clear federal guidelines, states have created a regulatory patchwork of often conflicting rules across the country. As one headline put it: “Headaches abound as states try to clarify [the] CBD landscape.” Some states, such as Maryland, have declared it illegal to add CBD to food products. Similarly, New York City regulators have embargoed food and drink products containing CBD. Media reports note that City officials have ordered at least five restaurants to stop selling CBD-containing food and drink products and that enforcement of the embargo includes fines ranging from $200 to $650. For 2020, the industry should watch how states continue to take action in the absence of clear federal guidance. For example, New York State recently passed a new law, effective in March 2020, that establishes a regulatory framework for the sale of CBD-containing products in the state.  State officials are expected to issue new regulations fleshing out the law in the coming weeks.
  • Class Action Litigation: Given the ambiguity around applicable rules surrounding CBD-containing products, particularly those in the food and beverage industry, private party litigation is expected to increase in the coming year. Already several federal class action lawsuits have been lodged against manufacturers of CBD products alleging that the products are “illegal to sell” and therefore violate state consumer protection laws.   While the CBD industry has expected an “avalanche” of class action cases for some time, the already-filed class action lawsuits suggest that the “CBD lawsuit floodgates are opening.”

Federal and state regulators are contemplating further action over the coming year. So too are additional private party plaintiffs, who are poised to present putative class action allegations given the “language of the FDA’s recent pronouncements and the widespread availability of CBD-containing products.” Manufacturers of CBD-containing products, particularly those in the food and beverage space, should be aware of these developments over the coming year.

Original Article Source: https://www.forbes.com/sites/tommytobin/2020/12/31/cbd-in-food–beverage-three-developments-to-watch-in-2020/

Comments

Post a Comment

Popular posts from this blog

Mormon Church Faces Potential Lawsuit Over Medical Marijuana Opposition

Political committees concerned with marijuana law reform in four states have waged an information war over the past year, first to qualify cannabis initiatives for the ballot, and then to support or oppose those measures in the lead-up to last week’s midterm elections. In total, over  $12.9 million in cash and in-kind services was spent attempting to convince voters about these marijuana ballot measures. Now that voters have had their say, Marijuana Moment decided to calculate how much each “yes” and “no” vote cost the committees on either side of the debate. Our calculations are based on dollars raised and disclosed before the election, since final totals of actual expenditures won’t be available until December or January reports required in the states that voted on cannabis. Michigan In Michigan, where voters approved marijuana legalization , our calculations show that the two anti-legalization committees spent about $1.28 per “no” vote, as they raised $2.37 million for ...
Post a Comment
Read more

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...
Post a Comment
Read more

NY Dem Chair Warns Against Passing Voter-Supported Marijuana Legalization Bill

The head of New York’s Democratic Party said on Thursday that if the state Senate votes on a marijuana legalization bill, his party’s lawmakers run the risk of alienating voters and losing reelection next year. Jay Jacobs, the state party chairman, claimed that several “far progressive” measures, including cannabis legalization, lack popularity in certain areas across the state such as Long Island and upstate New York. He cautioned lawmakers against putting the issue to a vote, arguing that voters would “throw us out of office.” “It could be the straw that breaks the camel’s back,” he told Newsday. Polling doesn’t support that conclusion, though. According to a March 2019 survey from Quinnipiac, 65 percent of New Yorkers are in favor of allowing adults to legally possess cannabis for personal use. That includes 63 percent of respondents in upstate New York and 65 percent of those living in the suburbs. Sixty-six percent of independents statewide also back ending marijuana prohibit...
Post a Comment
Read more